Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Shared Pathway Links Lou Gehrig's… >
Shared Pathway Links Lou Gehrig's Disease with Spinal Muscular Atrophy

Published: September 27, 2012.
By Harvard Medical School
http://hms.harvard.edu

Researchers of motor neuron diseases have long had a hunch that two fatal diseases, amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), might somehow be linked. A new study confirms that this link exists.

"Our study is the first to link the two diseases on a molecular level in human cells," said Robin Reed, Harvard Medical School professor of cell biology and lead investigator of the study.

The results will be published online in the September 27 issue of Cell Reports.

ALS, or Lou Gehrig's disease, which has an adult onset, affects neurons that control voluntary muscles. As a result, muscles start to weaken, and patients eventually lose the ability to move their arms, legs and other parts of the body. In contrast, patients who have SMA tend to be infants and young children. Symptoms are similar to ALS, with lack of ability to control muscles being the major symptom. In both diseases, the most common cause of death is the loss of muscle function in the chest, resulting in respiratory failure.

Previous studies have shown that one of the causes of ALS is mutation of the FUS gene, and that a deficiency in the survival of motor neuron (SMN) protein causes SMA disease. The SMN protein is present in bodies in the nucleus known as Gemini of Coiled Bodies, or gems. Reed's lab connected the FUS protein to the SMN protein and the formation of gems in cellular nuclei.

"Nobody really knows what the function of gems are," said Reed. "The consensus so far is that they might be involved in biogenesis of crucial nuclear RNAs."

The researchers arrived at this pathway by studying human fibroblasts, cells that form the basis of connective tissue. "Unlike other studies of ALS and SMA, in which post-mortem tissue is normally used, we used fibroblasts from patients. These cells are easily accessible because they can be obtained from patients' skin and may provide a better idea of what happens in the human body," said Reed.

Reed and colleagues began the study by showing that the FUS protein is essential for normal gem levels. Without it, gem levels in ALS fibroblasts are much lower than in control fibroblasts.

This feature of ALS fibroblasts led the team to connect the disease with SMA. Previous studies had shown that when cells were deficient in SMN protein, fibroblasts also lacked gems in the nuclei. The loss of gems as a final result in both the SMA and ALS pathways led Reed and her team to believe that they might, in fact, be part of one larger pathway.

"The question now is whether the loss of gems is a cause of the disease or a marker for the disease," said Reed.

Reed is hopeful that even if the loss of gems is a marker, it could be used as a diagnostic tool to determine if someone who is presenting symptoms has ALS. "We will need to find out if the loss of gems is applicable to all cases of ALS or if it is specific to ALS patients with mutations in the FUS gene," added Reed.

Either way, Reed describes these finds as killing two birds with one stone. "This common pathway may mean common treatment and resources."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Pathway 
4/13/11 

Small Molecules Inhibit Growth of Human Tumor Cells
By NYU Langone Medical Center / New York University School of Medicine
Wnt 
3/19/12 
New Genetic Path for Scleroderma: Patient Biopsies Reveal Potential New Target for Therapy
By Northwestern University
A genetic pathway previously known for its role in embryonic development and cancer has been identified as a target for systemic sclerosis, or scleroderma, therapy. The finding, discovered by …
Zebrafish 
7/9/12 
Zebrafish Provide Insights into Causes And Treatment of Human Diseases
By Genetics Society of America
BETHESDA, MD – July 6, 2012 – Zebrafish, popular as aquarium fish, now have an important place in research labs as a model organism for studying human diseases. …
Ras 
5/10/12 
★ 
Discovery in Cell Signaling Could Help Fight Against Melanoma
By University of Texas Health Science Center at Houston
The human body does a great job of generating new cells to replace dead ones but it is not perfect. Cells need to communicate with or signal to each …
Cholesterol 
1/14/13 
Scientists Find a New Way to Boost Common Cancer Drugs
By Fox Chase Cancer Center
PHILADELPHIA, PA (January 14, 2013)—Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research …
Mice 
8/29/12 

Could a Cancer Drug Potentially Prevent Learning Disabilities in Some Kids?
By University of Michigan Health System
Notch 
11/22/13 
Paths Not Taken: Notch Signaling Pathway Keeps Immature T Cells on the Right Track
By University of Pennsylvania School of Medicine
PHILADELPHIA - The lab of Avinash Bhandoola, PhD, professor of Pathology and Laboratory Medicine, has studied the origins of T cells for many years. One protein called Notch, which …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition